¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Overlapping lesion of digestive system"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • major histocompatibility system
    ÁÖÁ¶Á÷ÀûÇÕ°èÅë
  • monocyte-macrophage cell system
    ´ÜÇÙ±¸Å«Æ÷½Ä¼¼Æ÷°èÅë, ´ÜÇÙ±¸´ë½Ä¼¼Æ÷°èÅë
  • musculoskeletal system
    ±ÙÀ°»À´ë°èÅë, ±Ù°ñ°Ý°è
  • macrophage system
    Å«Æ÷½Ä¼¼Æ÷°èÅë, ´ë½Ä¼¼Æ÷°è
  • metric system
    ¹ÌÅ͹ý
  • nervous system
    ½Å°æ°èÅë, ½Å°æ°è
  • optical system
    ±¤Çаè
  • oxidation-reduction system
    »êȭȯ¿ø°è
  • picture archiving and communicating system
    ¿µ»óÀúÀå¹×Àü¼Ûü°è
  • portal system
    ¹®¸Æ°èÅë, ¹®¸Æ°è
  • projective system
    Åõ»çü°è
  • properdin system
    ÇÁ·ÎÆä¸£µò½Ã½ºÅÛ
  • parasympathetic nervous system
    ºÎ±³°¨½Å°æ°èÅë, ºÎ±³°¨½Å°æ°è
  • peripheral nervous system
    ¸»ÃʽŰæ°èÅë, ¸»ÃʽŰæ°è
  • renin-angiotensin-aldosterone system
    ·¹´Ñ-¾ØÁö¿ÀÅÙ½Å-¾Ëµµ½ºÅ׷аèÅë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • general system theory
    ÀϹÝü°è·Ð
  • genital system
    »ý½Ä°èÅë
  • genitourinary system
    ºñ´¢»ý½Ä°èÅë
  • global budget system
    ÃѾ׿¹»êÁ¦
  • health care system
    º¸°ÇÀÇ·áü°è
  • health care delivery system
    ÀÇ·áÀü´Þü°è
  • health information system
    º¸°ÇÁ¤º¸Ã¼°è
  • hematopoietic system
    Á¶Ç÷±â°ü°èÅë
  • hospital discharge abstract system
    Åð¿ø±â·Ï¿ä¾àÁ¦µµ
  • hospital information system
    º´¿øÁ¤º¸Ã¼°è
  • immobilization system
    °íÁ¤¹æ½Ä
  • immune system
    ¸é¿ªÃ¼°è
  • impulse conducting system
    ½ÉÀåÈïºÐÀüµµ°èÅë
  • information system
    Á¤º¸Ã¼°è
  • infusion-aspiration system
    ÁÖÀÔÈíÀÔÀåÄ¡
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • immune system
    ¸é¿ª°è(Øóæ¹Í§)
  • immunologic system
    ¸é¿ª°è.
  • impulse conducting system
    ÈïºÐÆÄÀüµµ°è.
  • impulse conduction system
    ÈïºÐÆÄÀüµµ°è.
  • impulse conduction system
    ÈïºÐÆÄÀüµµ°è(ýéÝÇ÷îîîÓôͧ).
  • inference system
    ÃßÃø°è
  • infusion-aspiration system
    ÁÖÀÔÈíÀÔÀåÄ¡
  • pituitary adrenal system
    ÇϼöüºÎ½ÅÇÇÁú°è(¡­Üùãìù«òõͧ).
  • pituitary portal system
    ³úÇϼöü¹®¸Æ°è(¡­Ú¦ØæÍ§).
  • pneumatic tube system
    ±â¼Û°üÀåÄ¡(ѨáêηíûöÇ)
  • portal system
    ¹®¸Æ°è(Ú¦ØæÍ§).
  • pressoreceptor nervous system
    ¾Ð·Â¼ö¿ë½Å°æ°è(¡­ãêÌèͧ).
  • pride system
    ÀÚ±àü°è£¨í»Ðèô÷ͧ£©
  • primary signal system
    ÀÏÂ÷½ÅÈ£°è(ìéó­ãáûÜ Í§).
  • primary signalling system
    ÀÏÂ÷Àû¡¡½Åȣü°è
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • anaerobic culture system
    ¹«»ê¼Ò¹è¾çÀåÄ¡, ¹«»ê¼Ò¹è¾ç±â, ¹«»ê¼ÒÀåÄ¡
  • ancillary immune system
    º¸Á¶Àû ¸é¿ª°è
  • anemia expert system
    ºóÇ÷Àü¹®°¡½Ã½ºÅÛ
  • annular phased array system, APAS
    À§»óµ¿±âÀ±»ó¹è¿­½Ã½ºÅÛ
  • archicortical system
    ¿ø½ÃÇÇÁú°è(¡­Í§)
  • array system
    ¹è¿­ ÀåÄ¡ (¹è¿­ ü°è)
  • autonomic nervous system
    ÀÚÀ²½Å°æ°èÅë, ÀÚÀ²½Å°æ°è(í»ëÏãêÌèͧ).
  • autonomic nervous system
    ÀÚÀ²½Å°æ°èÅë
  • autonomic nervous system
    ÀÚÀ²½Å°æ°è
  • autonomic nervous system
    ÀÚÀ²½Å°æ°è(í»×ÈãêÌèͧ)
  • bacterial culture system
    ¼¼±Õ¹è¾ç±â, ¼¼±Õ¹è¾çÀåÄ¡
  • bicarbonate buffer system
    Áßź»ê¿°¿ÏÃæ°è
  • bicarbonate buffer system
    Áßź»ê¿°¿ÏÃæ°è(ñì÷©ß«ç¤èÐõúͧ).
  • biliary system
    ´ã°ü°è(ÓÅηͧ), ´ãµµ°è(ÓÅԳͧ).
  • biliary system
    ´ãµµ°è(ÓÅԳͧ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
UMNL upper motor neuron lesion
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
MEOS Microsomal Ethanol Oxidizing System
  = MFOS; Mixed Function Oxidase System
TNM staging System standard Tumor, NOde & Metastasis staging system
ARMS adverse reaction monitoring system; amplification refractory mutation system
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
DSS Decision Support System
EMS Emergency Medical System
ENS Enteric Nervous System
ES Expert System
FARS Fatal Accident Reporting System
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • corticospinal system
    ÇÇÁú ô¼ö°è
  • countercurrent system
    ¿ª·ù°è, ´ëÇâ·ù°è
  • crystal system
    Á¤°è, °áÁ¤°è
  • cyclic AMP system
    ȯ»ó AMP °è
  • descending inhibitory system
    ÇÏÇà ¾ïÁ¦°è
  • disease of the lymphreticular system
    ¸²ÇÁ ¼¼¸Á³»ÇǰèÀÇ Áúȯ
  • DNA repair system
    DNA º¸¼ö ±â±¸
  • dopaminergic system
    µµÆÄ¹Î ü°è
  • drug delivery system
    ¾à¹° Åõ¿©±â, ¾à¹° Åõ¿© üÁ¦, ¾à¹° Àü´Þ ü°è
  • dual foil system
    ÀÌÁß ¹Ú¸· ±¸Á¶
  • ductal system
    µµ°ü°è
  • dynamic system
    µ¿Àû °èÅë
  • ectopic system
    »ýŰè
    ¾î¶² Áö¿ªÀÇ »ý¹° °øµ¿Ã¼¿Í À̰ÍÀ» À¯ÁöÇϰí ÀÖ´Â ¹«±âÀû ȯ°æÀÌ Á¾ÇÕµÈ ¹°Áú°è ¶Ç´Â ±â´É°è. »ýŰè¶õ ¿µ±¹ÀÇ A.G. ÅĽ½¸®¿¡ ÀÇÇÏ¿© 1935³â Á¦Ã¢µÈ ¿ë¾î·Î, ÀÚ¿¬ÀÇ ÀÖ´Â ±×´ë·ÎÀÇ »óŸ¦ ÀνÄÇϱâ À§Çؼ­´Â ÀÌ°Íµé »óÈ£°£ÀÇ °ü°è¸¦ Áö´Ñ »ý¹°°ú ¹«±âÀû ȯ°æÀ» Çϳª·Î ÅëÇÕÇØ¾ß ÇÑ´Ù´Â °ÍÀÌ ÅĽ½¸®°¡ Á¦Ã¢ÇÑ °³³äÀÌ´Ù. Áö±¸ »ýŰè´Â ±× ³ÐÀÌ¿¡¼­´Â »ý¹°±Ç°ú ÀÏÄ¡ÇÑ´Ù. ¹«±âÀû ȯ°æÀÇ Æ¯Â¡¿¡ ÀǰÅÇÏ¿© ÇØ¾ç »ýŰè, È£¼Ò »ýŰè, ±ØÁö »ýŰè, »ç¸· »ýÅÂ°è µîÀ¸·Î ±¸º°Çϰí, ¶Ç ±º¶ôÀÇ »ó°ü¿¡ µû¶ó¼­ »ï¸² »ýŰè, ÃÊÁö »ýÅÂ°è µîÀ¸·Î ±¸ºÐÇϱ⵵ ÇÑ´Ù. ¶ÇÇÑ, °æÁö »ýŰè, µµ½Ã »ýŰè¿Í °°Àº °Íµµ »ý°¢ÇÒ ¼ö ÀÖ´Ù. »ýŰè Áß¿¡¼­ »ý¹°Ã¼´Â ±â´ÉÀûÀ¸·Î »ý»êÀÚ
  • endocrine system
    ³»ºÐºñ°è
    ÀÎüÀÇ Á¶Àý ±â´ÉÀ¸·Î ¼¼Æ÷°£ÀÇ ´ëÈ­¸¦ È­ÇÐ ¹°ÁúÀΠȣ¸£¸óÀ» ÅëÇØ¼­ È­ÇÐÀûÀÎ ½ÅÈ£¸¦ ÀÌ¿ëÇÏ¿© Ç¥Àû ¼¼Æ÷µé¿¡ ÀÛ¿ëÇÑ´Ù. ÈçÇÑ ³»ºÐºñ°è ÀÌ»óÀº ºñÁ¤»óÀûÀÎ ¼ºÀå, ¿¡³ÊÁö ¼öÁØ º¯È­ ¿Âµµ º¯È­¿¡ÀÇ ºÎÀûÀÀ ¹× ¼³¸íµÇÁö ¾Ê´Â üÁß º¯È­·Î ³ªÅ¸³­´Ù. ´Ù´¢, °úµµÇÑ °¥Áõ, üÁß °¨¼Ò¸¦ µ¿¹ÝÇÑ ½Ä¿å °ú´Ù´Â ´ç´¢º´ÀÇ Æ¯Â¡ÀÌ´Ù. ½Ã·Â º¯È­, ½ÅÀå ±â´ÉÀå¾Ö, »çÁöÀÇ Ç÷¾× ¼øÈ¯ °¨¼Ò´Â Àå±â°£ÀÇ ´ç´¢·Î ÀÎÇÑ ÁøÇàµÈ Ç÷°ü °æÈ­ÀÇ Áõ»óÀÌ´Ù.
  • endogenous analgesic peptide system
    ³»¿ø¼º ÁøÅ뼺 ÆéƼµå°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
central nervous system neoplasms Neoplasms located in the brain, spinal cord, or meninges.
(12 Dec 1998)
central nervous system stimulants A loosely defined group of drugs that tend to increase behavioural alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
(12 Dec 1998)
glycogen debranching enzyme system 1,4-alpha-d-glucan-1,4-alpha-d-glucan 4-alpha-d-glucosyltransferase/dextrin 6 alpha-d-glucanohydrolase. An enzyme system having both 4-alpha-glucanotransferase (ec 2.4.1.25) and amylo-1,6-glucosidase (ec 3.2.1.33) activities. As a transferase it transfers a segment of a 1,4-alpha-d-glucan to a new 4-position in an acceptor, which may be glucose or another 1,4-alpha-d-glucan. As a glucosidase it catalyses the endohydrolysis of 1,6-alpha-d-glucoside linkages at points of branching in chains of 1,4-linked alpha-d-glucose residues. Amylo-1,6-glucosidase activity is deficient in glycogen storage disease type III.
(12 Dec 1998)
respiratory system The organs that are involved in breathing. These include the nose, throat, larynx, trachea, bronchi, and lungs.
(12 Dec 1998)
respiratory system abnormalities Congenital structural abnormalities of the respiratory system.
(12 Dec 1998)
respiratory system agents Drugs used for their effects on the respiratory system.
(12 Dec 1998)
reticular activating system <physiology> A physiological term denoting that part of the brainstem reticular formation that plays a central role in the organism's bodily and behavorial alertness.
It extends as a diffusely organised neural apparatus through the central region of the brainstem into the subthalamus and the intralaminar nuclei of the thalamus; by its ascending connections it affects the function of the cerebral cortex in the sense of behavioural responsiveness; its descending (reticulospinal) connections transmit its activating influence upon bodily posture and reflex mechanisms (e.g., muscle tonus), in part by way of the gamma motor neurons.
See: reticular formation.
Synonym: non-specific system.
(05 Mar 2000)
reticuloendothelial system The phagocytic system of the body, including the fixed macrophages of tissues, liver and spleen. Rather old fashioned term that is coming back into use, mononuclear phagocyte system is probably better when only phagocytes are meant.
(18 Nov 1997)
cerebrospinal system The combined central nervous system and peripheral nervous system.
(05 Mar 2000)
charge transfer system A complex between two organic molecules in which an electron from one (the donor) is transferred to the other (the acceptor), becoming generally distributed throughout the latter; subsequent transfer of a hydrogen atom completes the reduction of the acceptor; such complex's are generally highly coloured and may be so observed, a network of hydrogen bridges at the catalytic centre of certain proteases.
Synonym: charge transfer system.
(05 Mar 2000)
rh-hr blood-group system Erythrocyte isoantigens of the rh (rhesus) blood group system, the most complex of all human blood groups, because the genes differ by determining a different number of the over thirty antigens thus far described and do so with remarkably different quality. The major antigen rh or d is the most common cause of erythroblastosis foetalis.
(12 Dec 1998)
periodic system The arrangement of the chemical elements in a definite order as indicated by their respective atomic numbers in such a way that groups of elements with similar chemical properties (similar valence shell electron number) are grouped together.
See: Mendeleeff's law.
(05 Mar 2000)
peripheral nervous system One of the two major divisions of the nervous system. Nerves in the PNS connect the central nervous system (CNS) with sensory organs, other organs, muscles, bloodvessels and glands.
(22 May 1997)
peripheral nervous system agents Drugs that act principally at one or more sites within the peripheral neuroeffector systems, the autonomic system, and motor nerve-skeletal system.
(12 Dec 1998)
peripheral nervous system diseases Diseases of the peripheral nervous system, including disorders of the peripheral autonomic system, the cranial nerves, and the spinal nerves and roots, but not including neuromuscular and spinal cord diseases.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á